Log in

NASDAQ:SILKSilk Road Medical Stock Price, Forecast & News

$50.13
+0.10 (+0.20 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$49.21
Now: $50.13
$50.92
50-Day Range
$38.37
MA: $44.45
$50.03
52-Week Range
$20.84
Now: $50.13
$50.95
Volume181,294 shs
Average Volume418,964 shs
Market Capitalization$1.58 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.64
Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SILK
CUSIPN/A
CIKN/A
Phone408-720-9002

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$63.35 million
Book Value$2.33 per share

Profitability

Net Income$-52,420,000.00

Miscellaneous

Employees176
Market Cap$1.58 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableNot Optionable
$50.13
+0.10 (+0.20 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SILK News and Ratings via Email

Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

How has Silk Road Medical's stock been impacted by COVID-19 (Coronavirus)?

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SILK shares have increased by 35.0% and is now trading at $50.13.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Silk Road Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Silk Road Medical
.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Silk Road Medical
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical Inc (NASDAQ:SILK) posted its quarterly earnings data on Wednesday, August, 5th. The company reported ($0.32) earnings per share for the quarter, beating analysts' consensus estimates of ($0.38) by $0.06. The firm had revenue of $15.10 million for the quarter, compared to analyst estimates of $12.37 million. Silk Road Medical had a negative net margin of 54.94% and a negative return on equity of 44.17%. The business's revenue for the quarter was up .7% on a year-over-year basis. During the same period last year, the firm earned ($0.42) earnings per share.
View Silk Road Medical's earnings history
.

What price target have analysts set for SILK?

4 analysts have issued 1 year price objectives for Silk Road Medical's stock. Their forecasts range from $52.00 to $60.00. On average, they anticipate Silk Road Medical's share price to reach $56.25 in the next year. This suggests a possible upside of 12.2% from the stock's current price.
View analysts' price targets for Silk Road Medical
.

Has Silk Road Medical been receiving favorable news coverage?

Media stories about SILK stock have trended very positive recently, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Silk Road Medical earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
View the latest news about Silk Road Medical
.

Are investors shorting Silk Road Medical?

Silk Road Medical saw a decline in short interest in June. As of June 30th, there was short interest totaling 1,310,000 shares, a decline of 7.1% from the June 15th total of 1,410,000 shares. Based on an average daily trading volume, of 514,400 shares, the short-interest ratio is presently 2.5 days. Currently, 4.3% of the shares of the stock are short sold.
View Silk Road Medical's Current Options Chain
.

Who are some of Silk Road Medical's key competitors?

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Alibaba Group (BABA), Cisco Systems (CSCO), Home Depot (HD), Honeywell International (HON), Splunk (SPLK), Thermo Fisher Scientific (TMO), CVS Health (CVS), DexCom (DXCM), Raytheon Technologies (RTX) and Veeva Systems (VEEV).

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the following people:
  • Ms. Erica J. Rogers, Chief Exec. Officer, Pres & Director (Age 55)
  • Mr. Lucas W. Buchanan, Chief Financial Officer (Age 41)
  • Mr. Robert A. Nicholas, VP of Operations & Engineering (Age 56)
  • Mr. Andrew S. Davis, Exec. VP of Global Sales & Marketing (Age 50)
  • Ms. Alison Highlander, VP of HR

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Jennison Associates LLC (4.88%), TimesSquare Capital Management LLC (3.35%), Victory Capital Management Inc. (2.93%), Frontier Capital Management Co. LLC (1.66%), Peregrine Capital Management LLC (1.61%) and Rhenman & Partners Asset Management AB (0.44%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and X Finance LP Wp.
View institutional ownership trends for Silk Road Medical
.

Which institutional investors are selling Silk Road Medical stock?

SILK stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Rhenman & Partners Asset Management AB, Chartwell Investment Partners LLC, Steward Partners Investment Advisory LLC, and Carroll Financial Associates Inc.. Company insiders that have sold Silk Road Medical company stock in the last year include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, and Richard Ruedy.
View insider buying and selling activity for Silk Road Medical
.

Which institutional investors are buying Silk Road Medical stock?

SILK stock was purchased by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Jennison Associates LLC, TimesSquare Capital Management LLC, Victory Capital Management Inc., GW&K Investment Management LLC, Mutual of America Capital Management LLC, SG Americas Securities LLC, and Roubaix Capital LLC.
View insider buying and selling activity for Silk Road Medical
.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $50.13.

How big of a company is Silk Road Medical?

Silk Road Medical has a market capitalization of $1.58 billion and generates $63.35 million in revenue each year. The company earns $-52,420,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. Silk Road Medical employs 176 workers across the globe.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is www.silkroadmed.com.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.